Philippe Bedard
Philippe Bedard
Princess Margaret Cancer Centre
Geverifieerd e-mailadres voor
Geciteerd door
Geciteerd door
Tumour heterogeneity in the clinic
PL Bedard, AR Hansen, MJ Ratain, LL Siu
Nature 501 (7467), 355-364, 2013
The genetic basis for cancer treatment decisions
JE Dancey, PL Bedard, N Onetto, TJ Hudson
Cell 148 (3), 409-420, 2012
AACR Project GENIE: powering precision medicine through an international consortium
AACR Project Genie Consortium
Cancer discovery 7 (8), 818-831, 2017
Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling
HA Azim, S Michiels, PL Bedard, SK Singhal, C Criscitiello, M Ignatiadis, ...
Clinical cancer research 18 (5), 1341-1351, 2012
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
FE Vera-Badillo, AJ Templeton, P de Gouveia, I Diaz-Padilla, PL Bedard, ...
Journal of the National Cancer Institute 106 (1), djt319, 2014
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy
F Cardoso, PL Bedard, EP Winer, O Pagani, E Senkus-Konefka, ...
Journal of the National Cancer Institute 101 (17), 1174-1181, 2009
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance
C Kollmannsberger, T Tandstad, PL Bedard, G Cohn-Cedermark, ...
J Clin Oncol 33 (1), 51-7, 2015
Luminal-B breast cancer and novel therapeutic targets
B Tran, PL Bedard
Breast Cancer Research 13 (6), 221, 2011
A phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with …
PL Bedard, J Tabernero, F Janku, ZA Wainberg, L Paz-Ares, ...
Clinical Cancer Research 21 (4), 730-738, 2015
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
SY Shen, R Singhania, G Fehringer, A Chakravarthy, MHA Roehrl, ...
Nature 563 (7732), 579-583, 2018
Cancer genomics: technology, discovery, and translation
B Tran, JE Dancey, S Kamel-Reid, JD McPherson, PL Bedard, AM Brown, ...
J Clin Oncol 30 (6), 647-660, 2012
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
RK Murthy, S Loi, A Okines, E Paplomata, E Hamilton, SA Hurvitz, NU Lin, ...
New England Journal of Medicine 382 (7), 597-609, 2020
AKT inhibition in solid tumors with AKT1 mutations
DM Hyman, LM Smyth, MTA Donoghue, SN Westin, PL Bedard, EJ Dean, ...
Journal of Clinical Oncology 35 (20), 2251, 2017
A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors
TW Chen, AR Razak, PL Bedard, LL Siu, AR Hansen
Annals of Oncology 26 (9), 1824-1829, 2015
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
TL Stockley, AM Oza, HK Berman, NB Leighl, JJ Knox, FA Shepherd, ...
Genome medicine 8 (1), 1-12, 2016
Cardiac toxicity with anti-HER-2 therapies-what have we learned so far?
E de Azambuja, PL Bedard, T Suter, M Piccart-Gebhart
Targeted oncology 4 (2), 77-88, 2009
Abstract S5-07: preliminary efficacy and safety of pembrolizumab (MK-3475) in patients with PD-L1–positive, estrogen receptor-positive (ER+)/HER2-negative advanced breast …
HS Rugo, JP Delord, SA Im, PA Ott, SA Piha-Paul, PL Bedard, J Sachdev, ...
Cancer research 76 (4 Supplement), S5-07-S5-07, 2016
Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
PL Bedard, A Di Leo, MJ Piccart-Gebhart
Nature Reviews Clinical Oncology 7 (1), 22, 2010
Safety and antitumor activity of pembrolizumab in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer
HS Rugo, JP Delord, SA Im, PA Ott, SA Piha-Paul, PL Bedard, J Sachdev, ...
Clinical Cancer Research 24 (12), 2804-2811, 2018
Novel patterns of response under immunotherapy
E Borcoman, Y Kanjanapan, S Champiat, S Kato, V Servois, R Kurzrock, ...
Annals of Oncology 30 (3), 385-396, 2019
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20